676 related articles for article (PubMed ID: 21436726)
1. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
[TBL] [Abstract][Full Text] [Related]
2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
3. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
5. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
7.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
8. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of probiotics after colonoscopy.
D'Souza B; Slack T; Wong SW; Lam F; Muhlmann M; Koestenbauer J; Dark J; Newstead G
ANZ J Surg; 2017 Sep; 87(9):E65-E69. PubMed ID: 26183594
[TBL] [Abstract][Full Text] [Related]
10. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
Larsen N; Vogensen FK; Gøbel R; Michaelsen KF; Abu Al-Soud W; Sørensen SJ; Hansen LH; Jakobsen M
FEMS Microbiol Ecol; 2011 Mar; 75(3):482-96. PubMed ID: 21204871
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study.
Ringel-Kulka T; Goldsmith JR; Carroll IM; Barros SP; Palsson O; Jobin C; Ringel Y
Aliment Pharmacol Ther; 2014 Jul; 40(2):200-7. PubMed ID: 24853043
[TBL] [Abstract][Full Text] [Related]
12. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
13. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM
Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938
[TBL] [Abstract][Full Text] [Related]
14. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
West NP; Horn PL; Pyne DB; Gebski VJ; Lahtinen SJ; Fricker PA; Cripps AW
Clin Nutr; 2014 Aug; 33(4):581-7. PubMed ID: 24268677
[TBL] [Abstract][Full Text] [Related]
15. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
16. Influence of a probiotic mixture on antibiotic induced microbiota disturbances.
Forssten S; Evans M; Wilson D; Ouwehand AC
World J Gastroenterol; 2014 Sep; 20(33):11878-85. PubMed ID: 25206295
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
[TBL] [Abstract][Full Text] [Related]
18. Specific probiotics alleviate allergic rhinitis during the birch pollen season.
Ouwehand AC; Nermes M; Collado MC; Rautonen N; Salminen S; Isolauri E
World J Gastroenterol; 2009 Jul; 15(26):3261-8. PubMed ID: 19598302
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
20. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
